Project Grant R21NS135176

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $221K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $1,079,194 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to address the paradox of poor outcomes despite successful recanalization in stroke patients treated with endovascular stroke therapy (EVT). The award will fund a multi-year research effort to: 1) create a longitudinal clinical and imaging dataset to evaluate the...
The University of Texas Health Science Center at Houston (UTHealth) received a federal Project Grant award of $617,687 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program. The goal of this 5-year project is to build infrastructure for community-engaged research interventions focused on addressing racial and ethnic disparities in three key neurological...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,282,359.00 to the Regents of the University of Michigan to conduct research on the regulation of intermediate progenitor cells during neural development. The project aims to define the mechanisms that control the competency of neural stem cells to generate intermediate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $264,756 to the University of California, Los Angeles (UCLA) to conduct research on post-stroke neurovascular function and repair within a porous hydrogel. The key objectives are to examine the impact of a novel multi-component hydrogel scaffold with immobilized vascular...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $397,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to the Massachusetts Institute of Technology (MIT). The grant, effective May 1, 2025 through April 30, 2030, will support innovative research to study fundamental principles linking neurodevelopmental processes to the functional organization of neural circuits. The goal is to...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $9,213,665 Project Grant to the University of Texas Health Science Center at Houston (UTHealth) on September 19, 2023 to develop "Neural Recording and Simulation Tools to Address the Mesoscale Gap" under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). This grant will fund research to advance understanding of the human brain by developing improved neural...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, funds research at Tufts University to develop a hybrid differentiation strategy for generating region-specific neural and oligodendrocyte cell populations from human pluripotent stem cells. The project aims to optimize protocols for rapidly differentiating region-specific...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,008,977.00 to support research on the developmental topology of the human cerebral cortex. The key objectives are to improve understanding of human brain development and the origins of neurodevelopmental diseases by studying neural progenitor cell types in the outer...
This $458,189 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, funds research to investigate the role of membrane-remodeling factors in regulating oligodendrocyte morphology and myelination in the central nervous system. The research aims to: (1) identify the expression and sufficiency of membrane-remodeling factors in...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $582,246 to the University of Rochester to develop cutting-edge in vivo imaging and neurophysiology methods for studying the structural dynamics and functional impact of transplanted human neural precursor cells (NPCs) derived from induced pluripotent stem cells in the...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $221,120.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on improving neural progenitor cell survival and migration in the context of neurodegenerative diseases and brain injuries, such as stroke. The research investigates the potential of adult central nervous system endothelial cells to express developmental genes following epigenetic reprogramming, with the goal of guiding neural progenitor cell migration and enhancing neurovascular communication. The anticipated outcomes seek to contribute fundamental knowledge and potentially transform neural progenitor cell treatment strategies by combining vascular rejuvenation with neural progenitor cell transplantation to improve cognitive, motor, and overall clinical outcomes. The award period runs from Sep 1, 2024 to Aug 31, 2026.

Generated 6/17/25, 5:02 AM